Clinical Trial Update: A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy

View source ↗

Summary

A completed Korean cohort study evaluated tenofovir disoproxil fumarate rescue therapy in difficult-to-treat chronic hepatitis B, comparing TDF monotherapy with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Yonsei University | Conditions: The Difficult-to-treat Chronic Hepatitis B | Status: COMPLETED